Gourapura J Renukaradhya
Overview
Explore the profile of Gourapura J Renukaradhya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suresh R, Olaitan Comfort S, Dolatyabi S, Schrock J, Singh M, Renukaradhya G
Front Immunol
. 2025 Feb;
16:1509990.
PMID: 39981235
Salmonellosis, a gastrointestinal disease, continues to be one of the major public health concerns worldwide. Poultry meat and eggs are recognized as the major source of food poisoning in humans....
2.
Lakshmanappa Y, Shang P, Renu S, Dhakal S, Hogshead B, Xiao Y, et al.
Vet Microbiol
. 2025 Jan;
302:110391.
PMID: 39854919
Porcine reproductive and respiratory syndrome (PRRS) virus is a severe threat to the global swine industry. Modified live virus vaccines (MLVs) for two PRRSV species (PRRSV-1 and PRRSV-2) are the...
3.
Schrock J, Yan M, Dolatyabi S, Patil V, Yadagiri G, Renu S, et al.
Curr Microbiol
. 2024 Jul;
81(9):267.
PMID: 39003673
In this study, we evaluated the impact of human gut microbiota on the immune pathways in the respiratory tract using a gnotobiotic (Gn) piglet model. We humanized piglets with rural...
4.
Bugybayeva D, Dumkliang E, Patil V, Yadagiri G, Suresh R, Singh M, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932376
This study focuses on the development and characterization of an intranasal vaccine platform using adjuvanted nanoparticulate delivery of swine influenza A virus (SwIAV). The vaccine employed whole inactivated H1N2 SwIAV...
5.
Dolatyabi S, Renu S, Schrock J, Renukaradhya G
Poult Sci
. 2024 Mar;
103(5):103569.
PMID: 38447310
Non-typhoidal Salmonella infection is a significant health and economic burden in poultry industry. Developing an oral vaccine to induce robust mucosal immunity in the intestines of birds, especially cross protection...
6.
Hailstock T, Dai C, Aquino J, Walker K, Chick S, Manirarora J, et al.
Cytokine
. 2023 Dec;
174:156449.
PMID: 38141459
Research on C-X-C motif chemokine ligand 10 (CXCL10) has been widely reported for humans and select animal species, yet immune reagents are limited for pig chemokines. Our goal is to...
7.
Patil V, Hernandez-Franco J, Yadagiri G, Bugybayeva D, Dolatyabi S, Feliciano-Ruiz N, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006039
Swine influenza A viruses (SwIAVs) are pathogens of both veterinary and medical significance. Intranasal (IN) vaccination has the potential to reduce flu infection. We investigated the efficacy of split SwIAV...
8.
Hernandez-Franco J, Yadagiri G, Patil V, Bugybayeva D, Dolatyabi S, Dumkliang E, et al.
Vaccines (Basel)
. 2023 Nov;
11(11).
PMID: 38006031
The development of cross-protective vaccines against the zoonotic swine influenza A virus (swIAV), a potential pandemic-causing agent, continues to be an urgent global health concern. Commercially available vaccines provide suboptimal...
9.
Tabynov K, Solomadin M, Turebekov N, Babayeva M, Fomin G, Yadagiri G, et al.
Sci Rep
. 2023 Aug;
13(1):12485.
PMID: 37528132
No abstract available.
10.
Tabynov K, Solomadin M, Turebekov N, Babayeva M, Fomin G, Yadagiri G, et al.
Sci Rep
. 2023 Jul;
13(1):12115.
PMID: 37495639
We developed a novel intranasal SARS-CoV-2 subunit vaccine called NARUVAX-C19/Nano based on the spike protein receptor-binding domain (RBD) entrapped in mannose-conjugated chitosan nanoparticles (NP). A toll-like receptor 9 agonist, CpG55.2,...